Network signatures link hepatic effects of anti-diabetic interventions with systemic disease parameters

BMC Systems Biology

Volumn 8, Issue 1, 2014, Pages

  Kelder, Thomas ^a,d   Verschuren, Lars ^a   van Ommen, Ben ^a   van Gool, Alain J ^a,b,c   Radonjic, Marijana ^a,d  

^a TNO   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^d NONE   (Netherlands)

Author keywords

Metabolic health; Network biology; Systems biology; Transcriptomics; Type II diabetes mellitus

Indexed keywords

FENOFIBRATE; FLUORINATED HYDROCARBON; LOW DENSITY LIPOPROTEIN RECEPTOR; SULFONAMIDE; TO-901317; TRANSCRIPTOME;

ANIMAL; BIOLOGICAL MODEL; DIABETES MELLITUS, TYPE 2; DIET THERAPY; DISEASE COURSE; GENETICS; KNOCKOUT MOUSE; LIVER; METABOLISM; MOUSE; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; FENOFIBRATE; HYDROCARBONS, FLUORINATED; LIVER; MICE; MICE, KNOCKOUT; MODELS, BIOLOGICAL; RECEPTORS, LDL; SIGNAL TRANSDUCTION; SULFONAMIDES; TRANSCRIPTOME;

EID: 84907278920     PISSN: None     EISSN: 17520509     Source Type: Journal    
DOI: 10.1186/s12918-014-0108-0     Document Type: Article

References (54)

1. Barabási A-L, Gulbahce N, Loscalzo J. Network medicine: a network-based approach to human disease. Nat Rev Genet 2011, 12:56-68. 10.1038/nrg2918, 21164525.
2. Stumpf MPH, Thorne T, de Silva E, Stewart R, An HJ, Lappe M, Wiuf C. Estimating the size of the human interactome. Proc Natl Acad Sci U S A 2008, 105:6959-6964. 10.1073/pnas.0708078105, 18474861.
3. Croft D, O'Kelly G, Wu G, Haw R, Gillespie M, Matthews L, Caudy M, Garapati P, Gopinath G, Jassal B, Jupe S, Kalatskaya I, Mahajan S, May B, Ndegwa N, Schmidt E, Shamovsky V, Yung C, Birney E, Hermjakob H, D'Eustachio P, Stein L, Kataskaya I. Reactome: a database of reactions, pathways and biological processes. Nucleic Acids Res 2010, 39:D691-D697. 10.1093/nar/gkq1018, 21067998.
4. Kelder T, van Iersel MP, Hanspers K, Kutmon M, Conklin BR, Evelo CT, Pico AR. WikiPathways: building research communities on biological pathways. Nucleic Acids Res 2012, 40(Database issue):D1301-D1307. 10.1093/nar/gkr1074, 22096230.
5. Kelley R, Ideker T. Systematic interpretation of genetic interactions using protein networks. Nat Biotechnol 2005, 23:561-566. 10.1038/nbt1096, 15877074.
6. Rual J-F, Venkatesan K, Hao T, Hirozane-Kishikawa T, Dricot A, Li N, Berriz GF, Gibbons FD, Dreze M, Ayivi-Guedehoussou N, Klitgord N, Simon C, Boxem M, Milstein S, Rosenberg J, Goldberg DS, Zhang LV, Wong SL, Franklin G, Li S, Albala JS, Lim J, Fraughton C, Llamosas E, Cevik S, Bex C, Lamesch P, Sikorski RS, Vandenhaute J, Zoghbi HY, et al. Towards a proteome-scale map of the human protein-protein interaction network. Nature 2005, 437:1173-1178. 10.1038/nature04209, 16189514.
7. Gerstein MB, Kundaje A, Hariharan M, Landt SG, Yan K-K, Cheng C, Mu XJ, Khurana E, Rozowsky J, Alexander R, Min R, Alves P, Abyzov A, Addleman N, Bhardwaj N, Boyle AP, Cayting P, Charos A, Chen DZ, Cheng Y, Clarke D, Eastman C, Euskirchen G, Frietze S, Fu Y, Gertz J, Grubert F, Harmanci A, Jain P, Kasowski M, et al. Architecture of the human regulatory network derived from ENCODE data. Nature 2012, 489:91-100. 10.1038/nature11245, 22955619.
8. Waters KM, Liu T, Quesenberry RD, Willse AR, Bandyopadhyay S, Kathmann LE, Weber TJ, Smith RD, Wiley HS, Thrall BD. Network analysis of epidermal growth factor signaling using integrated genomic, proteomic and phosphorylation data. PLoS One 2012, 7:e34515. 10.1371/journal.pone.0034515, 22479638.
9. Caberlotto L, Lauria M, Nguyen T-P, Scotti M. The central role of AMP-kinase and energy homeostasis impairment in Alzheimer's disease: a multifactor network analysis. PLoS One 2013, 8:e78919. 10.1371/journal.pone.0078919, 24265728.
10. Metzker ML. Sequencing technologies - the next generation. Nat Rev Genet 2010, 11:31-46. 10.1038/nrg2626, 19997069.
11. Mann M. Proteomics for biomedicine: a half-completed journey. EMBO Mol Med 2012, 4:75-77. 10.1002/emmm.201100198, 22278912.
12. Thiele I, Swainston N, Fleming RMT, Hoppe A, Sahoo S, Aurich MK, Haraldsdottir H, Mo ML, Rolfsson O, Stobbe MD, Thorleifsson SG, Agren R, Bölling C, Bordel S, Chavali AK, Dobson P, Dunn WB, Endler L, Hala D, Hucka M, Hull D, Jameson D, Jamshidi N, Jonsson JJ, Juty N, Keating S, Nookaew I, Le Novère N, Malys N, Mazein A, et al. A community-driven global reconstruction of human metabolism. Nat Biotechnol 2013, 31(5):419-425. 10.1038/nbt.2488, 23455439.
13. Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics 2008, 9:559. 10.1186/1471-2105-9-559, 19114008.
14. Wang I-M, Zhang B, Yang X, Zhu J, Stepaniants S, Zhang C, Meng Q, Peters M, He Y, Ni C, Slipetz D, Crackower MA, Houshyar H, Tan CM, Asante-Appiah E, O'Neill G, Luo MJ, Thieringer R, Yuan J, Chiu C-S, Lum PY, Lamb J, Boie Y, Wilkinson HA, Schadt EE, Dai H, Roberts C. Systems analysis of eleven rodent disease models reveals an inflammatome signature and key drivers. Mol Syst Biol 2012, 8:594. 10.1038/msb.2012.24, 22806142.
15. Voineagu I, Wang X, Johnston P, Lowe JK, Tian Y, Horvath S, Mill J, Cantor RM, Blencowe BJ, Geschwind DH. Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Nature 2011, 474:380-384. 10.1038/nature10110, 21614001.
16. Hasan S, Bonde BK, Buchan NS, Hall MD. Network analysis has diverse roles in drug discovery. Drug Discov Today 2012, 00:1-6.
17. Brown JB, Okuno Y. Systems biology and systems chemistry: new directions for drug discovery. Chem Biol 2012, 19:23-28. 10.1016/j.chembiol.2011.12.012, 22284351.
18. Kasarskis A, Yang X, Schadt E. Integrative genomics strategies to elucidate the complexity of drug response. Pharmacogenomics 2011, 12:1695-1715. 10.2217/pgs.11.115, 22118053.
19. Leung A, Bader GD, Reimand J. HyperModules: identifying clinically and phenotypically significant network modules with disease mutations for biomarker discovery. Bioinformatics 2014, 30:2230-2232. 10.1093/bioinformatics/btu172, 24713437.
20. Hofree M, Shen JP, Carter H, Gross A, Ideker T. Network-based stratification of tumor mutations. Nat Methods 2013, 10:1108-1115. 10.1038/nmeth.2651, 24037242.
21. Nolan CJ, Damm P, Prentki M. Type 2 diabetes across generations: from pathophysiology to prevention and management. Lancet 2011, 378:169-181. 10.1016/S0140-6736(11)60614-4, 21705072.
22. Radonjic M, Wielinga PY, Wopereis S, Kelder T, Goelela VS, Verschuren L, Toet K, van Duyvenvoorde W, van der Werff van der Vat B, Stroeve JHM, Cnubben N, Kooistra T, van Ommen B, Kleemann R. Differential Effects of Drug Interventions and Dietary Lifestyle in Developing Type 2 Diabetes and Complications: A Systems Biology Analysis in LDLr-/-Mice. PLoS One 2013, 8:e56122. 10.1371/journal.pone.0056122, 23457508.
23. Rosenson RS. Fenofibrate: treatment of hyperlipidemia and beyond. Expert Rev Cardiovasc Ther 2008, 6:1319-1330. 10.1586/14779072.6.10.1319, 19018684.
24. Tontonoz P, Mangelsdorf DJ. Liver X receptor signaling pathways in cardiovascular disease. Mol Endocrinol 2003, 17:985-993. 10.1210/me.2003-0061, 12690094.
25. Kuhn M, Szklarczyk D, Franceschini A, Campillos M, von Mering C, Jensen LJ, Beyer A, Bork P. STITCH 2: an interaction network database for small molecules and proteins. Nucleic Acids Res 2010, 38(Database issue):D552-D556. 10.1093/nar/gkp937, 19897548.
26. Keating GM. Fenofibrate: a review of its lipid-modifying effects in dyslipidemia and its vascular effects in type 2 diabetes mellitus. Am J Cardiovasc Drugs 2011, 11:227-247. 10.2165/11207690-000000000-00000, 21675801.
27. Gerstein HC, Miller ME, Byington RP, Goff DC, Bigger JT, Buse JB, Cushman WC, Genuth S, Ismail-Beigi F, Grimm RH, Probstfield JL, Simons-Morton DG, Friedewald WT. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008, 358:2545-2559. 10.1056/NEJMoa0802743, 18539917.
28. Turinsky AL, Razick S, Turner B, Donaldson IM, Wodak SJ. Literature curation of protein interactions: measuring agreement across major public databases. Database (Oxford) 2010, 2010:baq026. 10.1093/database/baq026.
29. Shen Y, Yue F, McCleary DF, Ye Z, Edsall L, Kuan S, Wagner U, Dixon J, Lee L, Lobanenkov VV, Ren B. A map of the cis-regulatory sequences in the mouse genome. Nature 2012, 488(7409):116-120. 10.1038/nature11243, 22763441.
30. Ideker T, Krogan NJ. Differential network biology. Mol Syst Biol 2012, 8:565. 10.1038/msb.2011.99, 22252388.
31. Furuhashi M, Ura N, Murakami H, Hyakukoku M, Yamaguchi K, Higashiura K, Shimamoto K. Fenofibrate improves insulin sensitivity in connection with intramuscular lipid content, muscle fatty acid-binding protein, and beta-oxidation in skeletal muscle. J Endocrinol 2002, 174:321-329. 10.1677/joe.0.1740321, 12176671.
32. Jeong S, Yoon M. Fenofibrate inhibits adipocyte hypertrophy and insulin resistance by activating adipose PPARalpha in high fat diet-induced obese mice. Exp Mol Med 2009, 41:397-405. 10.3858/emm.2009.41.6.045, 19322024.
33. Efanov AM, Sewing S, Bokvist K, Gromada J. Liver X Receptor Activation Stimulates Insulin Secretion via Modulation of Glucose and Lipid Metabolism in Pancreatic Beta-Cells. Diabetes 2004, 53:S75-S78. 10.2337/diabetes.53.suppl_3.S75, 15561926.
34. Kharitonenkov A, Shiyanova TL, Koester A, Ford AM, Micanovic R, Galbreath EJ, Sandusky GE, Hammond LJ, Moyers JS, Owens RA, Gromada J, Brozinick JT, Hawkins ED, Wroblewski VJ, Li D-S, Mehrbod F, Jaskunas SR, Shanafelt AB. FGF-21 as a novel metabolic regulator. J Clin Invest 2005, 115:1627-1635. 10.1172/JCI23606, 15902306.
35. Berglund ED, Li CY, Bina HA, Lynes SE, Michael MD, Shanafelt AB, Kharitonenkov A, Wasserman DH. Fibroblast growth factor 21 controls glycemia via regulation of hepatic glucose flux and insulin sensitivity. Endocrinology 2009, 150:4084-4093. 10.1210/en.2009-0221, 19470704.
36. Wu M, Singh SB, Wang J, Chung CC, Salituro G, Karanam BV, Lee SH, Powles M, Ellsworth KP, Lassman ME, Miller C, Myers RW, Tota MR, Zhang BB, Li C. Antidiabetic and antisteatotic effects of the selective fatty acid synthase (FAS) inhibitor platensimycin in mouse models of diabetes. Proc Natl Acad Sci U S A 2011, 108:5378-5383. 10.1073/pnas.1002588108, 21389266.
37. Augustine KA, Rossi RM, Van G, Housman J, Stark K, Danilenko D, Varnum B, Medlock E. Noninsulin-dependent diabetes mellitus occurs in mice ectopically expressing the human Axl tyrosine kinase receptor. J Cell Physiol 1999, 181:433-447. 10.1002/(SICI)1097-4652(199912)181:3<433::AID-JCP7>3.0.CO;2-Y, 10528229.
38. Götte M. Syndecans in inflammation. FASEB J 2003, 17:575-591. 10.1096/fj.02-0739rev, 12665470.
39. Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006, 444:860-867. 10.1038/nature05485, 17167474.
40. Brazma A, Parkinson H, Sarkans U, Shojatalab M, Vilo J, Abeygunawardena N, Holloway E, Kapushesky M, Kemmeren P, Lara GG, Oezcimen A, Rocca-Serra P, Sansone S-A. ArrayExpress-a public repository for microarray gene expression data at the EBI. Nucleic Acids Res 2003, 31:68-71. 10.1093/nar/gkg091, 12519949.
41. Smyth GK. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 2004, 3:1.
42. Kanehisa M, Goto S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res 2000, 28(1):27-30. 10.1093/nar/28.1.27, 10592173.
43. Von Mering C, Jensen LJ, Snel B, Hooper SD, Krupp M, Foglierini M, Jouffre N, Huynen MA, Bork P. STRING: known and predicted protein-protein associations, integrated and transferred across organisms. Nucleic Acids Res 2005, 33(Database issue):D433-D437. 10.1093/nar/gki005.
44. Yusuf D, Butland SL, Swanson MI, Bolotin E, Ticoll A, Cheung WA, Zhang XYC, Dickman CTD, Fulton DL, Lim JS, Schnabl JM, Ramos OHP, Vasseur-Cognet M, de Leeuw CN, Simpson EM, Ryffel GU, Lam EW-F, Kist R, Wilson MSC, Marco-Ferreres R, Brosens JJ, Beccari LL, Bovolenta P, Benayoun BA, Monteiro LJ, Schwenen HDC, Grontved L, Wederell E, Mandrup S, Veitia RA, et al. The transcription factor encyclopedia. Genome Biol 2012, 13:R24. 10.1186/gb-2012-13-3-r24, 22458515.
45. Langfelder P, Zhang B, Horvath S. Defining clusters from a hierarchical cluster tree: the Dynamic Tree Cut package for R. Bioinformatics 2008, 24:719-720. 10.1093/bioinformatics/btm563, 18024473.
46. Falcon S, Gentleman R. Using GOstats to test gene lists for GO term association. Bioinformatics 2007, 23:257-258. 10.1093/bioinformatics/btl567, 17098774.
47. Ingenuity IPA Software.., http://www.ingenuity.com/products/pathways_analysis.html
48. Becker KG, Barnes KC, Bright TJ, Wang SA. The genetic association database. Nat Genet 2004, 36:431-432. 10.1038/ng0504-431, 15118671.
49. Yu W, Gwinn M, Clyne M. A navigator for human genome epidemiology. Nat Genet 2008, 40(2):124-125. 10.1038/ng0208-124, 18227866.
50. Flicek P, Amode MR, Barrell D, Beal K, Brent S, Chen Y, Clapham P, Coates G, Fairley S, Fitzgerald S, Gordon L, Hendrix M, Hourlier T, Johnson N, Kähäri A, Keefe D, Keenan S, Kinsella R, Kokocinski F, Kulesha E, Larsson P, Longden I, McLaren W, Overduin B, Pritchard B, Riat HS, Rios D, Ritchie GRS, Ruffier M, Schuster M, et al. Ensembl 2011. Nucleic Acids Res 2011, 39(Database issue):D800-D806. 10.1093/nar/gkq1064, 21045057.
51. Petryszak R, Burdett T, Fiorelli B, Fonseca NA, Gonzalez-Porta M, Hastings E, Huber W, Jupp S, Keays M, Kryvych N, McMurry J, Marioni JC, Malone J, Megy K, Rustici G, Tang AY, Taubert J, Williams E, Mannion O, Parkinson HE, Brazma A. Expression Atlas update-a database of gene and transcript expression from microarray- and sequencing-based functional genomics experiments. Nucleic Acids Res 2014, 42(Database issue):D926-D932. 10.1093/nar/gkt1270, 24304889.
52. Dupont P, Callut J, Dooms G, Monette JN, Deville Y, Sainte BP: Relevant subgraph extraction from random walks in a graph.Res Report RR 2006, 380167.
53. Csárdi G, Nepusz T. The igraph software package for complex network research. InterJournal Complex Syst 2006, 1695:1695.
54. Smoot ME, Ono K, Ruscheinski J, Wang P, Ideker T. Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics 2011, 27:431-432. 10.1093/bioinformatics/btq675, 21149340.